IS2366B - Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera - Google Patents

Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera

Info

Publication number: IS2366B
Authority: IS; Iceland
Prior art keywords: sup; hydrogen atom; alkyl; independently represent; drugs
Prior art date: 2001-07-26

Application number

IS7100A

Other languages

English (en)

Other versions

IS7100A (is

Inventor

Auguet Michel

Chabrier De Lassauniere Pierre-Etienne

Harnett Jeremiah

Original Assignee

Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-26

Filing date

2004-01-09

Publication date

2008-06-15

2004-01-09 Application filed by Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée filed Critical Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S), Société par Actions simplifiée

2004-01-09 Publication of IS7100A publication Critical patent/IS7100A/is

2008-06-15 Publication of IS2366B publication Critical patent/IS2366B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Oncology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Detergent Compositions (AREA)
Saccharide Compounds (AREA)
Accessory Of Washing/Drying Machine, Commercial Washing/Drying Machine, Other Washing/Drying Machine (AREA)
Cleaning By Liquid Or Steam (AREA)

IS7100A 2001-07-26 2004-01-09 Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera IS2366B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0109979A FR2827772B1 (fr)	2001-07-26	2001-07-26	Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mitochondries
PCT/FR2002/002660 WO2003009843A1 (fr)	2001-07-26	2002-07-25	Utilisation de derives de thiazoles pour preparer un medicament destine a proteger les mithochondries

Publications (2)

Publication Number	Publication Date
IS7100A IS7100A (is)	2004-01-09
IS2366B true IS2366B (is)	2008-06-15

Family

ID=8865922

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7100A IS2366B (is)	2001-07-26	2004-01-09	Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera

Country Status (25)

Country	Link
US (3)	US7345066B2 (is)
EP (1)	EP1414447B1 (is)
JP (1)	JP4491229B2 (is)
KR (1)	KR20040030843A (is)
CN (1)	CN1533276B (is)
AT (1)	ATE333876T1 (is)
AU (1)	AU2002341008B8 (is)
BR (1)	BR0211423A (is)
CA (1)	CA2455635C (is)
CY (1)	CY1106212T1 (is)
DE (1)	DE60213424T2 (is)
DK (1)	DK1414447T3 (is)
ES (1)	ES2268099T3 (is)
FR (1)	FR2827772B1 (is)
HU (2)	HU228783B1 (is)
IL (2)	IL159548A0 (is)
IS (1)	IS2366B (is)
MX (1)	MXPA04000752A (is)
NO (1)	NO334797B1 (is)
NZ (1)	NZ530368A (is)
PL (1)	PL206706B1 (is)
PT (1)	PT1414447E (is)
RU (1)	RU2297832C2 (is)
TW (1)	TWI309568B (is)
WO (1)	WO2003009843A1 (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7291641B2 (en) *	1999-10-11	2007-11-06	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US7101917B2 (en)	2003-04-14	2006-09-05	Hoffmann-La Roche Inc.	Mitochrondrial permeability transition pore affinity labels and modulators
US7915304B2 (en)	2006-10-24	2011-03-29	Congenia S.R.L.	Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT
KR100970814B1 (ko) *	2009-06-01	2010-07-16	주식회사 동아지질	석션 드레인 공법에 사용되는 배수재 연결구
JP6958860B2 (ja)	2017-11-07	2021-11-02	学校法人自治医科大学	ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4914207A (en) *	1989-05-09	1990-04-03	Pfizer Inc.	Arylthiazolylimidazoles
DE69123974T2 (de) *	1990-09-25	1997-05-07	Rhone-Poulenc Rorer International (Holdings) Inc., Greenville, Del.	Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen
HU9502843D0 (en) *	1995-09-29	1995-11-28	Livigene Ltd	Pharmaceutical composition
FR2764889B1 (fr) *	1997-06-20	2000-09-01	Sod Conseils Rech Applic	Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
DE69830410T2 (de) *	1997-08-29	2006-01-26	Tularik Ltd.	Meta-benzamidinderivate als serinprotease-inhibitoren
US6518292B1 (en) *	1999-03-12	2003-02-11	Bristol-Myers Squibb Co.	Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US6855715B1 (en) *	1999-06-14	2005-02-15	Eli Lilly And Company	Serine protease inhibitors
EP1205478A4 (en) *	1999-08-06	2004-06-30	Takeda Chemical Industries Ltd	P38MAP KINASE INHIBITORS
TWI292316B (en) *	1999-10-11	2008-01-11	Sod Conseils Rech Applic	Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
FR2800615B1 (fr) *	1999-11-05	2002-05-03	Sod Conseils Rech Applic	Produit comprenant au moins une substance inhibitrice des no synthases en association avec au moins une substance inhibitrice des phospholipases a2

2000
- 2000-07-13 HU HU0500484A patent/HU228783B1/hu unknown
2001
- 2001-07-26 FR FR0109979A patent/FR2827772B1/fr not_active Expired - Lifetime
2002
- 2002-07-18 TW TW091116026A patent/TWI309568B/zh not_active IP Right Cessation
- 2002-07-25 DE DE60213424T patent/DE60213424T2/de not_active Expired - Lifetime
- 2002-07-25 CN CN028145097A patent/CN1533276B/zh not_active Expired - Fee Related
- 2002-07-25 NZ NZ530368A patent/NZ530368A/en not_active IP Right Cessation
- 2002-07-25 MX MXPA04000752A patent/MXPA04000752A/es active IP Right Grant
- 2002-07-25 WO PCT/FR2002/002660 patent/WO2003009843A1/fr not_active Ceased
- 2002-07-25 CA CA2455635A patent/CA2455635C/fr not_active Expired - Fee Related
- 2002-07-25 JP JP2003515236A patent/JP4491229B2/ja not_active Expired - Fee Related
- 2002-07-25 EP EP02774830A patent/EP1414447B1/fr not_active Expired - Lifetime
- 2002-07-25 RU RU2004105653/15A patent/RU2297832C2/ru not_active IP Right Cessation
- 2002-07-25 US US10/483,823 patent/US7345066B2/en not_active Expired - Fee Related
- 2002-07-25 KR KR10-2004-7000996A patent/KR20040030843A/ko not_active Ceased
- 2002-07-25 PT PT02774830T patent/PT1414447E/pt unknown
- 2002-07-25 BR BR0211423-2A patent/BR0211423A/pt not_active Application Discontinuation
- 2002-07-25 IL IL15954802A patent/IL159548A0/xx unknown
- 2002-07-25 AU AU2002341008A patent/AU2002341008B8/en not_active Ceased
- 2002-07-25 ES ES02774830T patent/ES2268099T3/es not_active Expired - Lifetime
- 2002-07-25 AT AT02774830T patent/ATE333876T1/de active
- 2002-07-25 DK DK02774830T patent/DK1414447T3/da active
- 2002-07-25 PL PL368315A patent/PL206706B1/pl unknown
- 2002-07-25 HU HU0500557A patent/HU229425B1/hu not_active IP Right Cessation
2003
- 2003-12-24 IL IL159548A patent/IL159548A/en not_active IP Right Cessation
2004
- 2004-01-09 IS IS7100A patent/IS2366B/is unknown
- 2004-01-21 NO NO20040280A patent/NO334797B1/no not_active IP Right Cessation
2006
- 2006-10-23 CY CY20061101513T patent/CY1106212T1/el unknown
2007
- 2007-02-20 US US11/708,526 patent/US20070185174A1/en not_active Abandoned
- 2007-08-16 US US11/894,004 patent/US20080039451A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE333876T1 (de)	2006-08-15
PL368315A1 (en)	2005-03-21
DE60213424T2 (de)	2007-08-23
US20080039451A1 (en)	2008-02-14
EP1414447A1 (fr)	2004-05-06
KR20040030843A (ko)	2004-04-09
FR2827772B1 (fr)	2006-04-28
RU2004105653A (ru)	2005-04-10
HU0500484D0 (en)	2005-07-28
IL159548A0 (en)	2004-06-01
IS7100A (is)	2004-01-09
NZ530368A (en)	2005-04-29
WO2003009843A1 (fr)	2003-02-06
CA2455635A1 (fr)	2003-02-06
EP1414447B1 (fr)	2006-07-26
TWI309568B (en)	2009-05-11
HK1069326A1 (en)	2005-05-20
DK1414447T3 (da)	2006-11-27
PL206706B1 (pl)	2010-09-30
AU2002341008B8 (en)	2007-08-09
HUP0500484A3 (en)	2005-09-28
HUP0500557A3 (en)	2006-02-28
HU229425B1 (en)	2013-12-30
BR0211423A (pt)	2004-08-17
US20070185174A1 (en)	2007-08-09
HU228783B1 (en)	2013-05-28
MXPA04000752A (es)	2004-04-20
ES2268099T3 (es)	2007-03-16
JP4491229B2 (ja)	2010-06-30
CY1106212T1 (el)	2011-06-08
PT1414447E (pt)	2006-12-29
HUP0500557A2 (hu)	2005-09-28
US7345066B2 (en)	2008-03-18
CA2455635C (fr)	2011-05-31
AU2002341008B2 (en)	2007-03-08
CN1533276B (zh)	2010-06-30
US20040248885A1 (en)	2004-12-09
DE60213424D1 (de)	2006-09-07
IL159548A (en)	2009-11-18
FR2827772A1 (fr)	2003-01-31
JP2005500337A (ja)	2005-01-06
CN1533276A (zh)	2004-09-29
NO20040280L (no)	2004-01-21
RU2297832C2 (ru)	2007-04-27
AU2002341008A1 (en)	2003-02-17
NO334797B1 (no)	2014-05-26

Publication	Publication Date	Title
HUP0303037A2 (hu)	2004-03-01	Alzheimer-kór kezelésére alkalmas vegyületek és ezeket tartalmazó gyógyszerkészítmények
DK1054874T3 (da)	2002-12-30	Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
DK1389617T3 (da)	2007-05-07	Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel
ATE158288T1 (de)	1997-10-15	Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
NO20014925D0 (no)	2001-10-10	Farmasöytiske forbindelser
CY1111909T1 (el)	2015-11-04	Παραγωγα [[2-(αμινο-3,4-διοξο-1-κυκλοβουτεν-1-υλ)amino] αλκυλ]-οξεος για τη θεραπεια του πονου
PL1685142T3 (pl)	2008-06-30	Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
ATE498600T1 (de)	2011-03-15	Inden derivate als pharmazeutika
DK1847534T3 (da)	2011-08-29	Thiadiazolin-derivater til behandling af kræft
IS7100A (is)	2004-01-09	Notkun á þíasólafleiðum til framleiðslu á lyfi til að vernda hvatbera
ES2184467T3 (es)	2003-04-01	Derivados de la piperacina para la inhibicion de la replicacion del virus de la inmunodeficiencia humana.
AR010098A1 (es)	2000-05-17	COMPOSICION Y PROCEDIMIENTO PARA LA DEFORMACION PERMANENTE DEL CABELLO, Y PROCEDIMIENTO DE PREPARACIoN DE DICHA COMPOSICION
WO2005011697A3 (en)	2005-04-21	Sulfonamide derivatives with activity on protein kinase a and b
CY1106104T1 (el)	2011-06-08	Αναστολεις φαρναζυλτρανσφepασης
DK0604186T3 (da)	1997-06-16	HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DK1644385T3 (da)	2008-01-02	Siliciumforbindelser og deres anvendelse
CO5200761A1 (es)	2002-09-27	Nuevos derivados de equinocandina, su procedimiento de preparacion y su aplicacion como antifungicos
BG106156A (en)	2002-05-31	Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
DK0485219T3 (da)	1996-07-22	Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
MXPA04000371A (es)	2004-05-04	6- (2-tolil) - triazolopirimidinas substituidas.
DE60108209D1 (de)	2005-02-10	Fungizide Phenylimidate-Derivate
CO5210951A1 (es)	2002-10-30	Mezclas fungicidas sinergicas de una azolopirimidina y una fenoxiamida inhibidora de la biosisntesis de melanina
TW200508211A (en)	2005-03-01	2-naphthylimino-1,3-thiazine derivatives
MY126230A (en)	2006-09-29	Fungicidal mixtures
BR9812928B1 (pt)	2013-03-19	derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica.